Literature DB >> 19217450

A study of acid phosphatase locus 1 in women with high fat content and normal body mass index.

Antonino De Lorenzo1, Laura Di Renzo, Alberto Puja, Patrizia Saccucci, Fulvia Gloria-Bottini, Egidio Bottini.   

Abstract

De Lorenzo and coworkers have recently described a class of women with normal body mass index (BMI) and high fat content (normal weight obese syndrome [NWO]). This observation prompted us to study the possible role of acid phosphatase locus 1 (ACP(1)) in the differentiation of this special class of obese subjects. Acid phosphatase locus 1 is a polymorphic gene associated with severe obesity and with total cholesterol and triglycerides levels. The enzyme is composed by 2 isoforms--F and S--that have different biochemical properties and probably different functions. The sample study was composed of 130 white women from the population of Rome. Total fat mass and percentage of fat mass were measured by dual-energy x-ray absorptiometry. Thirty-six women had a BMI less than 25 and percentage of fat mass greater than 30 (high fat, normal BMI [HFHB]), and 94 women showed a BMI greater than 25 and a percentage of fat mass greater than 30 (high fat, high BMI [HFHB]). In the whole sample, the proportion of low-activity ACP(1) genotypes (*A/*A and *B/*A) was higher than in controls. However, whereas HFNB showed a very high frequency of ACP(1) *A/*A genotype, high-fat, high-BMI women showed an increase of *B/*A genotype. These 2 genotypes differ in the concentration of F isoform and the F/S ratio, which are lower in ACP(1)*A/*A genotype than in ACP(1)*B/*A genotype. The genetic differentiation of the class of women with normal BMI and high fat content from the class showing a concordant level of the 2 parameters supports the hypothesis that HFNB class represents a special cluster of obese subjects not revealed by BMI evaluation. Because ACP(1) is present in adipocytes, the present observation suggests that F isoform may have a specific role in the regulation of quantity of adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217450     DOI: 10.1016/j.metabol.2008.10.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Early-onset obesity and paternal 2pter deletion encompassing the ACP1, TMEM18, and MYT1L genes.

Authors:  Martine Doco-Fenzy; Camille Leroy; Anouck Schneider; Florence Petit; Marie-Ange Delrue; Joris Andrieux; Laurence Perrin-Sabourin; Emilie Landais; Azzedine Aboura; Jacques Puechberty; Manon Girard; Magali Tournaire; Elodie Sanchez; Caroline Rooryck; Agnès Ameil; Michel Goossens; Philippe Jonveaux; Geneviève Lefort; Laurence Taine; Dorothée Cailley; Dominique Gaillard; Bruno Leheup; Pierre Sarda; David Geneviève
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

2.  Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.

Authors:  Vincent Gagné; Anne Aubry-Morin; Maria Plesa; Rachid Abaji; Kateryna Petrykey; Pascal St-Onge; Patrick Beaulieu; Caroline Laverdière; Nathalie Alos; Jean-Marie Leclerc; Stephen E Sallan; Donna Neuberg; Jeffery L Kutok; Lewis B Silverman; Daniel Sinnett; Maja Krajinovic
Journal:  Pharmacogenomics       Date:  2019-11-05       Impact factor: 2.533

Review 3.  New obesity classification criteria as a tool for bariatric surgery indication.

Authors:  Antonino De Lorenzo; Laura Soldati; Francesca Sarlo; Menotti Calvani; Nicola Di Lorenzo; Laura Di Renzo
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

4.  A new patient with a terminal de novo 2p25.3 deletion of 1.9 Mb associated with early-onset of obesity, intellectual disabilities and hyperkinetic disorder.

Authors:  Maria Clara Bonaglia; Roberto Giorda; Sergio Zanini
Journal:  Mol Cytogenet       Date:  2014-08-05       Impact factor: 2.009

5.  Association between -308 G/A TNF-α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome.

Authors:  L Di Renzo; F Sarlo; L Petramala; L Iacopino; G Monteleone; C Colica; A De Lorenzo
Journal:  Dis Markers       Date:  2013-10-30       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.